Issue: Assistive technology
Ian C. Langtree – Content Writer/Editor for Disabled World
Published: 2024/09/26
Post type: Product launch, update
Content: Summary – Introduction – Main article – Related topics
Synopsis: Neurode offers an alternative to traditional ADHD medications by using light electrical stimulation directed to the prefrontal cortex of the brain. As ADHD diagnoses increase, especially among adults, Neurode sees a growing demand for alternative treatments. Neurode’s device uses light electrical stimulation directed to the prefrontal cortex for 20 minutes a day. The device aims to improve concentration, memory and impulse control by balancing brain activity. It connects to a smartphone app that monitors brain activity and tracks changes over time.
Why it is important: Neurode’s innovative ADHD management device is important because it offers a non-invasive, drug-free alternative to treating ADHD symptoms. The headband uses light electrical stimulation to target the prefrontal cortex, potentially improving concentration, memory, and impulse control in just 20 minutes of daily use. Unlike traditional medications, which can have side effects and may not work for everyone, Neurode’s approach addresses the neurological and behavioral aspects of ADHD. Additionally, the device’s ability to measure and track brain activity provides objective data on symptom improvement, addressing a long-standing challenge in ADHD treatment. This personalized, data-driven approach to ADHD management could revolutionize treatment options for millions of people around the world struggling with this disorder. Disabled world.
Introduction
An innovative new company aims to change the way attention deficit hyperactivity disorder (ADHD) is managed, avoiding the traditional route of medication to instead use non-invasive light electrical brain stimulation delivered through a headband worn for just 20 minutes a day.
Main article
Neurode, an Australian company founded by Nathalie Gouailhardou – a neuroscientist who was diagnosed with ADHD when she was five – and engineer Damian Sofrevski, has raised AU$5.3 million (US$3.7 million) to launch its device to the market, and has a waiting list. of thousands who want to try the product in its development stage.
Continued…
For the more than 366 million people worldwide living with ADHD (and these 2020 statistics are now considered an underestimate), treatment remains largely trial and error, with many trying different medications before finding one (and the proper dosage) that helps. Then there is the added difficulty of restricted access to medications, with the most popular treatments – short-acting stimulants such as dexamfetamine and methylphenidate (Ritalin) and slow-release stimulants such as lisdexamfetamine (Vyvanse) – being controlled substances, which have varying degrees red in color. ribbon attached for access depending on where you live. In some countries, such as Japan, dexamphetamine is banned.
More and more adults are diagnosed with ADHD. This is because our understanding of ADHD has evolved: many younger girls were overlooked in their school years because they have more symptoms of inattention than the hyperactive subtype, so we are seeing many women in their 20s and 30s who are diagnosed with ADHD.
Neurode’s goal is to make the treatment of ADHD and the self-management of its many complex and varied symptoms much easier (since there is no cure) through light electrical stimulation applied to the prefrontal cortex (PFC), the region of the brain that controls the executive system. function and focus. So far, users have reported feeling nothing while wearing the headband or a slight tingling sensation.
Continued…
According to Neurode, traditional ADHD medications, such as Ritalin and Adderall, are not helpful for the 366 million people worldwide who are affected by ADHD. While therapy and lifestyle adjustments can be beneficial, many find it difficult to stick to those routines.
The Neurode headband uses light electrical stimulation directed to the prefrontal cortex, the part of the brain responsible for concentration and executive function. This gentle stimulation helps balance brain activity; Some users report a slight tingling sensation, while others feel nothing at all.
Continued…
Used for 20 minutes a day, the creators say the brain stimulation helps control concentration, memory and impulse control, key components of executive function that make daily life for people with ADHD very challenging. . Neurode also connects to a brain monitoring app, providing real-time data via a smartphone app. It measures brain activity and tracks PFC changes over time, which in turn should reflect how symptoms related to executive function improve.
“Our breakthrough is to take a large, expensive brain imaging device, reduce the cost 100-fold, and make it portable for everyday use, without sacrificing data quality. We combine this with a non-invasive way to balance brain activity to improve concentration. , memory and impulsivity without side effects, that’s what makes Neurode different,” said Gouailhardou. “We raised $5.3 million to refine our product, complete a clinical trial and now launch our private beta where people can try the headband and give feedback,” Gouailhardou said.
People can sign up for the beta at Neurode website.
Page information, citations and disclaimer
Disabled World is a comprehensive online resource providing information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004, our website covers a wide range of topics, including disability rights, healthcare, education, employment and independent living, with the goal of supporting the disability community and their families.
Cite this page (APA): Langtree, I.C. (September 26, 2024). Neurode: the portable device for the treatment of ADHD without invasive procedures. Disabled world. Retrieved September 27, 2024 from www.disabled-world.com/assistivedevices/neurode.php
Permanent link: Neurode: the portable device to control ADHD without invasive procedures: Neurode offers an alternative to traditional ADHD medications by using light electrical stimulation directed to the prefrontal cortex of the brain.
Disabled World provides general information only. The materials presented are never intended to be a substitute for qualified medical care. Any third party offers or advertisements do not constitute an endorsement.
